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analgesia alone in patients undergoing minimally
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Objective: This prospective randomized double-blind study examined the effect of
local wound infusion of anesthetics on pain control in the thoracotomy wound of
patients undergoing minimally invasive cardiac surgery.
Methods: Patients who underwent coronary artery bypass grafting or cardiac valvular
procedures via a minimally invasive thoracotomy were studied. Patients were enrolled
and randomly allocated to two groups with different modalities of postoperative an-
algesia. The thoracotomy wound infusion group received 0.15% bupivacaine infused
continuously at 2 mL/h through a catheter embedded in the wound, as well as intra-
venous patient-controlled analgesia. The control group had patient-controlled analge-
sia alone with a sham thoracotomy wound infusion of normal saline. Verbal analog
pain scores (0–10 points) and recovery profiles were investigated.
Results: There were 19 patients in each group for complete data analysis. On the first
day after the operation, infusion of local anesthetics significantly reduced the verbal
analog pain scores both at rest and during motion (thoracotomy wound infusion vs
control). The improved pain relief with thoracotomy wound infusion persisted at
day 3 and even at 3 months after the operation. No difference was noted about time
to extubation, length of intensive care unit stay, or hospital stay.
Conclusion: In this controlled double-blind study, thoracotomy wound infusion and
patient-controlled analgesia were superior to patient-controlled analgesia alone in
reducing pain at 1, 3, and 90 days after minimally invasive cardiac surgery.
A
minimally invasive approach for cardiac surgery (valvular repair/replace-
ment and/or coronary artery bypass) has become a feasible (and sometimes
superior) alternative to conventional sternotomy.1,2 It not only provided bet-
ter cosmetic outcome, but also improved quality of life, promoted more rapid recov-
ery, reduced blood transfusion, and reduced intensive care unit and hospital
recoveries.3-5 It may also be a safer approach for redo operations.6,7
However, the typical thoracotomy causes more severe pain than sternotomy.8,9
Thus, an effective analgesic regimen is important because it can not only reduce
pain and discomfort but also improve postoperative lung function,10 allow for earlier
tracheal extubation, and decrease the incidence of pulmonary complications and car-
diac dysrhythmia.11-14 Among various methods of analgesia, thoracic epidural anal-
gesia is thought to provide better pain control and avoid the potential bleeding
complication associated with nonsteroidal anti-inflammatory agents (NSAIDs) or
the respiratory depression commonly seen with parenteral opioids.13 In some modal-
ities, it may also decrease chronic wound pain.15 These benefits are accompanied by
greater technical challenges and, in the setting of cardiac surgery and anticoagulation,
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ICU 5 intensive care unit
NSAID 5 nonsteroidal anti-inflammatory agent
PCA 5 patient-controlled analgesia
the greater risk of epidural hematoma and possible neuro-
logic deficits compared with lumbar epidural.16 Safe and ef-
fective methods to control pain in minimally invasive cardiac
surgical procedures are critical to patient well-being.
Delivery of local anesthetics to the wound is a simple and
safe method of analgesia. It is effective in iliac crest harvest
site,17,18 sternotomy of cardiac surgery,19 and hysterectomy.20
It is not effective in total knee arthroplasty21 or radical prosta-
tectomy.22 We hypothesize that the thoracotomy wound infu-
sion of local anesthetic combined with patient-controlled
analgesia (PCA) would provide better pain relief than PCA
alone after minimally invasive cardiac surgery.
Patients and Methods
After institutional approval and written informed consent, we en-
rolled patients undergoing minimally invasive cardiac surgery (cor-
onary or valvular surgery) through thoracotomy. Participant were
excluded if they underwent emergency surgery, received extracor-
poral membrane oxygenation support, had preoperative nonsinus
cardiac rhythm, or had a history of peptic ulcer disease or preoper-
ative renal insufficiency. Anesthesia was induced with etomidate 0.2
to 0.3 mg/kg, fentanyl 5 to 10 mg/kg, and rocuronium 1mg/kg.
Anesthesia was maintained with sevoflurane. Double-lumen endo-
tracheal intubation (Broncho-Cath Left; Mallinckrodt Medical, Ath-
lone, Ireland) was used to achieve one-lung ventilation during
surgery. Coronary artery bypass surgery was performed through
a left thoracotomy via the fourth or fifth intercostal space without
cardiopulmonary bypass. Valvular surgery was through a right lat-
eral thoracotomy with transthoracic clamp technique performed
via the fourth intercostal space with cardiopulmonary bypass.
Participants were randomly assigned to thoracotomy wound in-
fusion or sham infusion through a multi-orifice catheter (Portex Epi-
dural Catheter 18-gauge; Smiths Medical ASD Inc, Keene, NH)
placed at the subcutaneous layer during wound closure. After 10
mL (0.15% bupivacaine or saline solution) at the end of the opera-
tion, the catheter was connected to a continuously infusing container
(Two-Day Infusor 2 mL/h Portable Elastomeric Infusion System;
Baxter Healthcare Corporation, Deerfield, Ill), which delivered
0.15% bupivacaine or saline solution at a rate of 2 mL/h. The nurse
connecting the infusion bag to the catheter, the surgeons, the patient,
and the nurse evaluating the pain score were all blinded to the nature
of the infusion. PCA was used as the rescuing method of pain con-
trol in all patients. Its solution contained morphine 0.5 mg/mL, fen-
tanyl 5 mg/mL, and tenoxicam 0.8 mg/mL with a basal infusion rate
of 0.1 mL/h, bolus dose of 1 mL, and a lockout period of 15 minutes,
delivered by Aim Plus (Abbott Laboratories, North Chicago, Ill).
Participants were visited by members of the pain service every 8
hours to document PCA dosage, resting and motion verbal analog
scores (0–10; 0 5 no pain; 10 5 worst pain imaginable). At eachThe Journal of Thorvisit, resting pain score was recorded first; then the patient was asked
to take a deep breath and the increasing pain intensity that resulted
was recorded as the motion pain score. If the patient was still intu-
bated, we asked whether he or she had a pain score of 10 points.
If this was not the case, we repeated the question decreasing the
score 1 point at a time until the patient confirmed the answer by nod-
ding. If the patient’s conscious state did not allow pain evaluation
(Sedation-Agitation Scale# 2 or$ 6), his or her data were removed
from analysis. The thoracotomy wound infusion catheter was re-
moved 48 hours after the operation. The intravenous PCA was
changed to another pain control method (oral or parenteral NSAIDs
or opioids) at 72 hours after the operation. We documented PCA re-
quirements in the first 72 hours. The demographic data of patients,
comorbidity, extubation time, duration of intensive care unit (ICU)
stay and hospital stay, wound complications, and arrhythmia were
recorded. At 90 days after the operation, we evaluated each patient’s
intensity of wound pain by telephone.
Statistics
In a pilot investigation, patients using only PCA had a mean
pain score 36 1.0. Assuming a reduction in the mean pain score
to 2 after addition of bupivacaine wound infusion to be clini-
cally significant, 16 patients were needed in each group to
achieve 80% power and 95% significance. We enrolled 20 pa-
tients in each group. The c2 and Fisher exact tests were used to
examine the categorical data. The Mann–Whitney U test was
used to reveal the differences of pain scores and other continu-
ous variables. Noncategorical data were expressed as mean6
standard deviation. A p value of less than 0.05 was considered
significant. All statistic results were calculated by the small
STATA 8.2 version (Stata Corporation, College Station, Tex).
Results
Forty patients were enrolled, with 1 patient in each group be-
ing excluded as a result of protocol violation (limited con-
sciousness), which left 19 patients in each group for full
data analysis. There were no significant differences between
the sham and bupivacaine infusion groups in gender, age,
height, and weight, or major systemic diseases (Table 1).
The distribution of surgical procedure was also similar.
There were no differences in time to extubation, ICU, or
hospital stay. Although not statistically significant, there ap-
peared to be a trend in reduction of PCA requirements when
bupivacaine was infused into the wound (Table 1). In the first
72 hours there were no differences in arrhythmia, and in the
first 3 months there were no differences in wound complica-
tions such as infection or dehiscence between the sham and
bupivacaine infusion groups.
The sham infusion group had greater and more persistent
pain than the bupivacaine infusion group (Figure 1). Not only
did the bupivacaine wound infusion reduce pain during the
first 48-hour infusion period, but it also provided reduced
pain at 24 hours after cessation of the infusion. At 3 months
after the operation, the bupivacaine infusion group had sig-
nificantly less pain than the sham infusion group.acic and Cardiovascular Surgery c Volume 135, Number 6 1349
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In this study, we documented improved early (72 hours) and
late (3 months) pain relief with thoracotomy wound infusion
of bupivacaine in minimally invasive cardiac surgery.
Wound perfusion of local anesthetics effectively reduced
pain in many different surgical settings.17,19,20,22-27 To our
knowledge, there is little information concerning the pain-
reducing effect of local anesthetic wound infusion in thora-
cotomy wound for minimally invasive cardiac surgery. One
retrospective study did demonstrate that a 4-mL/h infusion
of 0.25% bupivacaine reduced pain scores and narcotic use
compared with epidural analgesia after thoracotomy.28
TABLE 1. Demographic data and perioperative
characteristics
Sham group
(n 5 19)
TWI
(n 5 19)
P
value
Demographic data
Gender (M/F) 12:7 13:6 NS
Age (y) 57.4 6 15.2 59.7 6 13.8 NS
Height (m) 1.59 6 0.08 1.62 6 0.10 NS
Weight (kg) 63.6 6 12.9 63 6 10.4 NS
Comorbidity
Diabetes 4 2 NS
Hypertension 9 7 NS
Old stroke 1 0 NS
Obstructive lung disease 0 1 NS
Surgery type
Coronary artery bypass 5 6 NS
Valve surgery 14 13 NS
Perioperative characteristics
Operation time (h) 4.3 6 0.7 4.2 6 0.8 NS
Extubation time (h) 11.3 6 8.9 14.4 6 22.0 NS
ICU stay (h) 56.0 6 22.6 55.6 6 30.6 NS
Hospital stay (d) 12.0 6 8.4 9.0 6 3.6 NS
IVPCA consumption (mL)
24 h 36.3 6 17.3 26.8 6 11.0 .095
48 h 67.6 6 30.3 56.4 6 22.4 .092
72 h 91.4 6 40.7 70.5 6 26.4 .117
TWI, Thoracotomy wound infusion; ICU, intensive care unit; IVPCA, intrave-
nous patient-controlled analgesia; NS, not significant.Very few studies have compared the efficacy of different
pain control modalities in minimally invasive cardiac sur-
gery. This study may be the first prospective trial demonstrat-
ing superior efficacy of local anesthetic infusion in the
thoracotomy wound, especially for cardiac surgery.
Of substantial importance is that the reduction in pain 24
hours after the bupivacaine infusion was discontinued was
not fully anticipated. However, the reduction in wound
pain at 3 months was a remarkable and significant clinical
finding. Local anesthetic infusion has been shown to improve
both acute and chronic pain at the iliac crest bone harvest
site.18 Peripheral and central pain sensitization contributes
to persistence of acute pain and induction of chronic
pain.29 The concept of pre-emptive analgesia was first intro-
duced on the belief that by reducing initial pain sensitization,
pain-controlling drugs or methods could be more effective in
reducing acute pain and even chronic pain if administered be-
fore rather than after tissue injury.30-32 Pre-emptive analgesia
has been recently challenged as a result of conflicting results
in large trials in some surgical settings.33-35 Recent evidence
shows that perioperative afferent input of sensitized nocicep-
tors is of great importance in pain sensitization and chronic
pain formation.36 This was demonstrated not only by the re-
duction in acute pain, but also by a reduction in chronic pain 3
months after iliac crest bone harvesting with wound infusion
of ropivacaine.18 In our study, the local anesthetic infusion
was initiated at the time of wound closure before emergence
from general anesthesia. This provided uninterrupted analge-
sia contributing to short- and long-term pain relief.
Effective pain control has been associated with reduced
time to extubation and pulmonary complication.12,13 This is
thought to be a result of reduced chest splinting caused by
pain with deep breathing. In this study, wound infusion of bu-
pivacaine reduced pain both at rest and while taking a deep
breath, yet it did not reduce time to extubation. This may
be due to a difference in the practice of our ICU. Weaning
profile was not evaluated until several hours after surgery.
Our effort in reducing pain did not change the practice of
our ICU colleagues. There is large variation in the recovery
profile (Table 1), and numerous factors affecting time to ex-
tubation including preoperative lung function, postoperativePain at Rest
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Figure 1. Placement of the epidural
catheter in the wound and the fixed
catheter circled with 5–0 Prolene poly-
propylene (Ethicon, Inc, Somerville,
NJ).
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make the benefit of reduced pain less significant.
Reduced requirement for analgesics is often used as a pa-
rameter to evaluate the effectiveness of specific analgesic pro-
cedures. In this study, there was a trend of reducing PCA
requirements in the bupivacaine infusion group. Increasing
the group size may have revealed a difference in this out-
come. However, reduced pain at all intervals in the bupiva-
caine group supports this analgesic regimen.
Delivered through a catheter embedded in the wound dur-
ing closure, the infusion of local anesthetics is a simple method
that has little effect on the duration of surgery (Table 1).
The placement of a thoracic epidural catheter would cause
further delay and increase operating room expenditures.
The major concern of local anesthetic infusion is neurologic
or cardiovascular toxicity of local anesthetics. A 4-mL/h in-
fusion of 0.5% or 0.25% bupivacaine in the sternotomy re-
sulted in safe serum concentrations (,2 mg/mL) in the
study by White and associates19 We did not document serum
concentrations, yet there was no observation of arrhythmias
in the bupivacaine group.
Local anesthetic infusion is a relatively new technique in
minimally invasive cardiac surgery. There is a large amount
of literature on analgesic use after thoracotomy for lung sur-
gery; however, data on analgesic methods in minimally inva-
sive cardiac surgery is still inadequate. Additional studies
comparing opioid, thoracic epidural analgesia, intercostal
block, and wound infusion of local anesthetics are needed
to determine the most effective and safest method of pain
control. As clinical trials are published and as clinical expe-
rience increases, the optimal analgesic modalities or com-
bined modalities will optimize the risk/benefit/expense ratio.
Conclusion
Localized wound infusion of bupivacaine is a simple and
highly effective alternative to parenteral opioid analgesia,
which substantially reduces acute and chronic pain in patients
undergoing minimally invasive cardiac surgery.
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